CEL-SCI slides after pricing $2.5M best-efforts common stock offering at $1.00/share

CEL-SCI Corporation (CVM) slides 7.4% in premarket after pricing its "best-efforts" public offering of 2.5M shares of common stock at $1.00 per share. The company expects to bring in $2.5M in total ...
Yahoo Finance

CEL-SCI Reports Fiscal 2025 Results

VIENNA, Va., December 29, 2025--(BUSINESS WIRE)--CEL-SCI Corporation (NYSE American: CVM) reported financial results for the fiscal year ended September 30, 2025, as well as key clinical and corporate ...
TMCnet

CEL-SCI and Saudi Amarox to Conduct Signing Ceremony at BIO 2026 for Strategic Agreement to Advance Commercialization and Distribution of Multikine® in Saudi Arabia

CEL-SCI Corporation (NYSE American: CVM) today announced it will participate in a formal signing ceremony with Saudi Amarox ("Amarox") during the BIO International Convention 2026 in San Diego, ...
CNET

Cel-Fi Plug and Play review: Capable cell signal booster for a price

Former CNET editor Dong Ngo has been involved with technology since 2000, starting with testing gadgets and writing code for CNET Labs' benchmarks. He managed CNET's San Francisco Labs, reviews 3D ...
Cure Today

Cema-Cel Has Durable Responses in in Relapsed/Refractory Large B-Cell Lymphoma

Cema-cel demonstrated durable responses in relapsed/refractory large B-cell lymphoma, with high overall and complete response rates comparable to autologous CAR-T therapies. The safety profile of cema ...